Works matching IS 13419625 AND DT 2022 AND VI 27 AND IP 12

Results: 14

List of reviewers 2021–2022.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1916, doi. 10.1007/s10147-022-02254-1
Publication type:
Article
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
Published in:
2022
By:
- Sugawara, Shunichi;
- Kondo, Masashi;
- Yokoyama, Toshihide;
- Kumagai, Toru;
- Nishio, Makoto;
- Goto, Koichi;
- Nakagawa, Kazuhiko;
- Seto, Takashi;
- Yamamoto, Nobuyuki;
- Kudou, Kentarou;
- Asato, Takayuki;
- Zhang, Pingkuan;
- Ohe, Yuichiro
Publication type:
Correction Notice
Combining nutritional status with TNM stage: a physiological update on gastric cancer staging for improving prognostic accuracy in elderly patients.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1849, doi. 10.1007/s10147-022-02250-5
By:
- Sugawara, Kotaro;
- Yamashita, Hiroharu;
- Urabe, Masayuki;
- Uemura, Yukari;
- Okumura, Yasuhiro;
- Yagi, Koichi;
- Aikou, Susumu;
- Seto, Yasuyuki
Publication type:
Article
Tumor–stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1818, doi. 10.1007/s10147-022-02249-y
By:
- Sakai, Toshihiko;
- Saito, Yuki;
- Tateishi, Yoko;
- Yamazawa, Sho;
- Fukuoka, Osamu;
- Kobayashi, Kenya;
- Omura, Go;
- Akashi, Ken;
- Yoshida, Masafumi;
- Ando, Mizuo;
- Ebihara, Yasuhiro;
- Yamasoba, Tatsuya
Publication type:
Article
Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1867, doi. 10.1007/s10147-022-02248-z
By:
- Iwasawa, Tomohiro;
- Kosaka, Takeo;
- Yasumizu, Yota;
- Hongo, Hiroshi;
- Yanai, Yoshinori;
- Baba, Yuto;
- Matsumoto, Kazuhiro;
- Nakamura, Kohei;
- Nishihara, Hiroshi;
- Oya, Mototsugu
Publication type:
Article
Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1795, doi. 10.1007/s10147-022-02242-5
By:
- Kondo, Shunsuke;
- Iwasa, Satoru;
- Koyama, Takafumi;
- Fujita, Tomoko;
- Sugibayashi, Ko;
- Murayama, Kosho;
- Yamamoto, Noboru
Publication type:
Article
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1874, doi. 10.1007/s10147-022-02246-1
By:
- Shoji, Tadahiro;
- Takatori, Eriko;
- Nagasawa, Takayuki;
- Kagabu, Masahiro;
- Baba, Tsukasa;
- Shigeto, Tatsuhiko;
- Matsumura, Yukiko;
- Shimizu, Dai;
- Terada, Yukihiro;
- Seino, Manabu;
- Ohta, Tsuyoshi;
- Nagase, Satoru;
- Shigeta, Shogo;
- Tokunaga, Hideki;
- Shimada, Muneaki;
- Kaiho-Sakuma, Michiko;
- Furukawa, Shigenori;
- Soeda, Shu;
- Watanabe, Takafumi;
- Takahashi, Fumiaki
Publication type:
Article
Long non-coding RNA NR2F2-AS1 regulates human osteosarcoma growth and metastasis through miR-425-5p-mediated HMGB2.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1891, doi. 10.1007/s10147-022-02245-2
By:
- Ye, Jia;
- He, Hui;
- Chen, Sen;
- Ren, Yijun;
- Guo, Weichun;
- Jin, Zhihui
Publication type:
Article
Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1904, doi. 10.1007/s10147-022-02244-3
By:
- Leung, Karen K. Y.;
- Ray, Samiran;
- Chan, Godfrey C. F.;
- Hon, Kam Lun
Publication type:
Article
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study).
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1859, doi. 10.1007/s10147-022-02243-4
By:
- Matsuoka, Hiroshi;
- Yamada, Takeshi;
- Ohta, Ryo;
- Yoshida, Yoichiro;
- Watanabe, Tatsuyuki;
- Takahashi, Makoto;
- Kosugi, Chihiro;
- Fukazawa, Atsuko;
- Kuramochi, Hidekazu;
- Matsuda, Akihisa;
- Sonoda, Hiromichi;
- Yoshida, Hiroshi;
- Hasegawa, Suguru;
- Sakamoto, Kazuhiro;
- Otsuka, Toshiaki;
- Hirata, Keiji;
- Koda, Keiji
Publication type:
Article
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1881, doi. 10.1007/s10147-022-02247-0
By:
- Campos, Susana;
- Matulonis, Ursula;
- Berlin, Suzanne;
- Horowitz, Neil;
- Liu, Joyce;
- Krasner, Carolyn;
- Hang, Lee;
- Zarwan, Corrine;
- Barry, William;
- Colella, Tina;
- Whalen, Christen;
- Shoni, Melina;
- Lundquist, Christine;
- Birrer, Michael J.;
- Penson, Richard
Publication type:
Article
Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1841, doi. 10.1007/s10147-022-02241-6
By:
- Kasai, Takashi;
- Mori, Kiyoshi;
- Sugiyama, Tomohide;
- Koyama, Nobuyuki;
- Nakamura, Yoichi;
- Ohyanagi, Fumiyoshi;
- Fukuda, Hiroki;
- Hoshi, Eishin;
- Kobayashi, Kunihiko;
- Nakayama, Mitsuo
Publication type:
Article
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1805, doi. 10.1007/s10147-022-02233-6
By:
- Takahashi, Shunji;
- Oridate, Nobuhiko;
- Tanaka, Kaoru;
- Shimizu, Yasushi;
- Fujimoto, Yasushi;
- Matsumoto, Koji;
- Yokota, Tomoya;
- Yamazaki, Tomoko;
- Takahashi, Masanobu;
- Ueda, Tsutomu;
- Hanai, Nobuhiro;
- Yamaguchi, Hironori;
- Hara, Hiroki;
- Yoshizaki, Tomokazu;
- Yasumatsu, Ryuji;
- Nakayama, Masahiro;
- Shiga, Kiyoto;
- Fujii, Takashi;
- Mitsugi, Kenji;
- Takahashi, Kenichi
Publication type:
Article
Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.
Published in:
International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1828, doi. 10.1007/s10147-022-02232-7
By:
- Sugawara, Shunichi;
- Kondo, Masashi;
- Yokoyama, Toshihide;
- Kumagai, Toru;
- Nishio, Makoto;
- Goto, Koichi;
- Nakagawa, Kazuhiko;
- Seto, Takashi;
- Yamamoto, Nobuyuki;
- Kudou, Kentarou;
- Asato, Takayuki;
- Zhang, Pingkuan;
- Ohe, Yuichiro
Publication type:
Article